IMARC Group, a leading market research company, has recently releases report titled “Artificial Vital Organs and Medical Bionics Market Report by Product Type (Artificial Vital Organs, Medical Bionics), Application (Hospitals, Clinics, and Others), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the artificial vital organs and medical bionics market share.

How Big is the Artificial Vital Organs and Medical Bionics Market?

The global artificial vital organs and medical bionics market size reached US$ 47.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 72.1 Billion by 2032, exhibiting a growth rate (CAGR) of 4.72% during 2024-2032. 

Industry Overview of Artificial Vital Organs and Medical Bionics

Artificial vital organs are medical devices designed to take over the function of essential organs that have failed or are impaired. They aim to replicate the core tasks of organs like the heart, lungs, or kidneys. Medical bionics refers to the science of creating artificial devices or systems that can mimic the function of biological systems within the human body. They can replace or augment natural biological functions, which improves the quality of life for patients who have lost those functions due to disease, injury, or congenital issues.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/artificial-vital-organs-medical-bionics-market/requestsample

What are the growth prospects and trends in the artificial vital organs and medical bionics industry?

The increasing number of cases related to kidney, heart, and liver failure and chronic obstructive pulmonary disease (COPD) represents one of the primary factors driving the demand for artificial vital organs and medical bionics around the world.

Moreover, the rising awareness about the availability and benefits of medical bionics and artificial organs is favoring the growth of the market. In addition, the growing standard of healthcare institutions and the availability of specialized care are promoting the use of medical bionics and artificial organs.

Apart from this, the increasing number of global partnerships in medical research and technology and extensive research and development (R&D) projects are influencing the market positively.

Leading Companies Operating in the Global artificial vital organs and medical bionics Industry:

• Abiomed
• BiVACOR Inc
• CARMAT
• Cirtec Medical
• Edwards Lifesciences
• Ekso Bionics Holdings Inc.
• Nikkiso Co. Ltd.
• Second Sight Medical Products Inc
• SynCardia Systems LLC (Picard Medical Inc.)

Artificial Vital Organs and Medical Bionics Market Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product Type:

• Artificial Vital Organs
  • Artificial Liver
  • Artificial Heart
  • Artificial Pancreas
  • Artificial Kidney
  • Artificial Lungs
  • Oxygenators
• Medical Bionics
  • Bionic Limbs
  • Vision Bionics
  • Ear Bionics
  • Exoskeletons
  • Brain Bionics
  • Heart Valves
  • Cardiac Bionics

Breakup by Application:

• Hospitals
• Clinics
• Others

Breakup by Region:

• North America: (United States, Canada)

• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America: (Brazil, Mexico, Others)

• Middle East and Africa

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163